000 01324 a2200373 4500
005 20250516001748.0
264 0 _c20100915
008 201009s 0 0 eng d
022 _a1533-4406
024 7 _a10.1056/NEJMcibr1006328
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShackleton, Mark
245 0 0 _aMoving targets that drive cancer progression.
_h[electronic resource]
260 _bThe New England journal of medicine
_cAug 2010
300 _a885-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCell Line, Tumor
650 0 4 _aDisease Progression
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHistone Deacetylase Inhibitors
_xtherapeutic use
650 0 4 _aHistone Demethylases
_xmetabolism
650 0 4 _aHistones
_xmetabolism
650 0 4 _aHumans
650 0 4 _aJumonji Domain-Containing Histone Demethylases
650 0 4 _aMelanoma
_xmetabolism
650 0 4 _aMice
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aNuclear Proteins
_xmetabolism
650 0 4 _aRepressor Proteins
_xmetabolism
650 0 4 _aTransplantation, Heterologous
773 0 _tThe New England journal of medicine
_gvol. 363
_gno. 9
_gp. 885-6
856 4 0 _uhttps://doi.org/10.1056/NEJMcibr1006328
_zAvailable from publisher's website
999 _c20151575
_d20151575